Coeptis Therapeutics (COEP) Insider Trading & Ownership $8.40 -0.27 (-3.11%) As of 03:59 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock Coeptis Therapeutics (NASDAQ:COEP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage24.25%Number OfInsiders Buying(Last 3 Years)6Amount OfInsider Buying(Last 3 Years)$77.79KNumber OfInsiders Selling(Last 3 Years)0 Get COEP Insider Trade Alerts Want to know when executives and insiders are buying or selling Coeptis Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address COEP Insider Buying and Selling by Quarter Coeptis Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/12/2024Tara DesilvaDirectorBuy113$11.60$1,310.80 1/10/2024Brian CogleyCFOBuy250$13.40$3,350.00 1/8/2024David MehalickCEOBuy1,000$13.20$13,200.00 1/5/2024Daniel Alexander YeraceVPBuy542$13.80$7,479.60 1/5/2024David MehalickCEOBuy252$13.80$3,477.60 1/5/2024Gene SalkindDirectorBuy580$13.80$8,004.00 8/29/2023Gene SalkindDirectorBuy200$20.20$4,040.00 8/25/2023Gene SalkindDirectorBuy1,431$18.20$26,044.20 8/23/2023Chris CaliseDirectorBuy579$18.80$10,885.20 (Data available from 1/1/2013 forward) COEP Insider Trading Activity - Frequently Asked Questions Who is on Coeptis Therapeutics's Insider Roster? The list of insiders at Coeptis Therapeutics includes Brian Cogley, Chris Calise, Daniel Alexander Yerace, David Mehalick, Gene Salkind, and Tara Desilva. Learn more on insiders at COEP. What percentage of Coeptis Therapeutics stock is owned by insiders? 24.25% of Coeptis Therapeutics stock is owned by insiders. Learn more on COEP's insider holdings. Which Coeptis Therapeutics insiders have been buying company stock? The following insiders have purchased COEP shares in the last 24 months: Brian Cogley ($3,350.00), Chris Calise ($10,885.20), Daniel Alexander Yerace ($7,479.60), David Mehalick ($16,677.60), Gene Salkind ($38,088.20), and Tara Desilva ($1,310.80). How much insider buying is happening at Coeptis Therapeutics? Insiders have purchased a total of 4,947 COEP shares in the last 24 months for a total of $77,791.40 bought. Coeptis Therapeutics Key ExecutivesMr. David Mehalick (Age 55)Co-Founder, Chairman of the Board, CEO & President Compensation: $360kMs. Christine Elise Sheehy (Age 56)Co-Founder and VP of Compliance & Corporate Secretary Compensation: $151kMr. Daniel Alexander Yerace (Age 41)Co-Founder, VP of Operations & Director Compensation: $360kMr. Brian Cogley M.B.A. (Age 37)Chief Financial Officer Compensation: $208kDr. Colleen Delaney M.D. (Age 56)M.Sc., CSO & Chief Medical Officer Compensation: $360k More Insider Trading Tools from MarketBeat Related Companies Protalix BioTherapeutics Insider Trades Cabaletta Bio Insider Trades C4 Therapeutics Insider Trades Invivyd Insider Trades Atossa Therapeutics Insider Trades Caribou Biosciences Insider Trades Corbus Pharmaceuticals Insider Trades Anixa Biosciences Insider Trades Zentalis Pharmaceuticals Insider Trades IO Biotech Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Summer Stocks With Insider Buying and Analyst Support3 Tightly-Held Growth Stocks Set Up for Short SqueezesTankers, Takedowns & Air Taxis: Insiders Are Buying These 3 Names3 Tech Stocks Insiders Are Buying: Speculative Plays for JuneDividend Investors Looking for an Edge? 3 Stocks Insiders Bought This page (NASDAQ:COEP) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coeptis Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Coeptis Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy COEP Stock Free COEP Stock Alerts